Background
Uveitis is the most common extra-articular manifestation of juvenile idiopathic arthritis (JIA). This sight-threatening condition contributes significantly to the disease burden of JIA [
1,
2]. Chronic insidious uveitis in JIA is often asymptomatic, and it is a major challenge to diagnose the condition as early as possible for prompt and adequate treatment [
3,
4]. The diagnosis may be obvious in cases with acute uveitis [
5], but the challenge remains to provide optimal screening programs and treatment to minimize long-term complications in all forms of JIA-associated uveitis. The reported prevalence of uveitis in JIA varies highly, and ethnic and geographic differences seem to exist. Recent publications show a prevalence of 8–25% in most Caucasian populations [
6,
7], while some studies from other continents show lower percentage of uveitis, 1 to 7% [
8,
9]. Young age at onset of arthritis and presence of ANA were predictors of uveitis in most studies [
3,
10‐
12]. In some larger cohort studies and registries, oligoarticular onset category and female gender were also statistically significant predictors of uveitis, but with less clinical impact [
3,
13].
Histones are subcomponents of chromatin where these basic DNA-binding proteins are found in highly organized nucleosomal particles [
14]. Antihistone antibodies (AHA) are among the ANA subtypes identified in subsets of children with JIA, while other subtypes associated with connective tissue diseases such as anti-DNA, anti-RNP, anti-SSA and anti-SSB antibodies are rarely found [
15,
16]. AHA were reported to be associated with early-onset JIA, oligoarthritis and uveitis [
17]. We showed previously that AHA is a significant predictor of chronic uveitis in a Norwegian JIA cohort [
11]. Whether this association is merely an epiphenomenon is not yet known, although new interest for histones in autoimmune diseases has emerged through recent epigenetic findings [
18,
19].
A longitudinal cohort study of JIA in a population-based setting in the Nordic countries started in 1997 and is still ongoing [
20,
21]. The ophthalmologic data of a follow-up 8 years after disease onset of this Nordic JIA cohort were analyzed in the present study. The main objective was to describe the incidence and the predictors of uveitis in JIA during the first decade after disease onset. We also wanted to extend the previous Norwegian pilot study to the Nordic JIA cohort regarding the presence of histone antibodies in patients with JIA with and without uveitis, respectively.
Discussion
In this Nordic multicenter JIA study, we found a high cumulative incidence of uveitis, and a geographic difference with a higher incidence in Finland compared to Norway, Sweden and Denmark. Young age at onset of arthritis, ANA and AHA were significant predictors of uveitis, but stratified for gender both young age at onset and AHA were significant predictors only in girls. Mean serum levels of AHA were higher in the uveitis group than in the children with no uveitis.
The prospective, longitudinal design and population-based context are the strengths of this multi-center study. The proportion of children lost to follow-up was small compared to other longitudinal studies [
26‐
29]. A weakness is the few patients in each JIA category that made analyses of uveitis and its predictors in some of the categories less reliable. Another weakness is that information on uveitis such as differentiation between acute and chronic uveitis were registered from available ophthalmologic records by the pediatric rheumatologists and not by the ophthalmologists themselves.
The high rate of uveitis in our population is in line with previous findings in the Nordic countries [
6,
11,
30,
31]. A prevalence of 8–15% was reported from Sweden [
30,
32], 14–18% in northern Norway [
11,
31], 9–19% in Denmark [
33,
34], while higher rates were previously reported from Finland (24%) [
6,
35]. Even though the background rate of HLA-B27 is reported to be higher in northern areas such as Finland and northern Norway [
36,
37], we did not find this in our cohort from the Helsinki area in the southern part of Finland. There were also no differences in the presence of ANA between countries. The higher incidence of uveitis during the first 8 years of disease in Finland compared to the other Nordic countries in the present study may be explained by the trend of younger age at onset of arthritis in Finland and/or genetic differences. This finding is in line with the striking worldwide ethnic and genetic differences in uveitis incidence, differences beyond what can be expected by variations in patient accrual and study design. In two large studies from North America of multiethnic populations both Saurenmann et al. and Angeles-Han et al. found that uveitis was more common among Caucasians than among children of black American, Arab and Indian origin [
12,
13]. Our cohort was of mostly Caucasian origin.
In line with other studies we found that the risk of developing uveitis during the first year was more than 6 times the risk during the second year, and almost 16-fold the risk during the fifth year after onset of arthritis. This underlines the need for immediate eye examination in children with onset of non-septic or non-specific arthritis even before the diagnosis of JIA is confirmed, and frequent early follow-up when a diagnosis of JIA has been established. Even though a clear majority of 82% developed uveitis within the first 4 years, our data show that uveitis may develop late in the JIA disease course. An important finding was that 4 cases of uveitis developed more than 8 years after onset of arthritis. Of these cases 2 were asymptomatic uveitis, which may not have been diagnosed without long-term screening. Zak et al. found in their 26-years follow-up of a Danish JIA cohort that both new onset of uveitis and complications may develop late [
26]. Based on these data long-term ophthalmologic follow-up into adulthood must be considered.
Robust predictors of uveitis will help selecting high-risk children for frequent eye examinations to ensure early diagnosis and treatment. In acute uveitis with symptoms, the diagnosis is easy and predictors not that important, but the differentiation between acute and chronic uveitis is not always clear, and young children may have difficulties expressing complaints of a painful acute uveitis. In line with most publications we have therefore chosen to analyze predictors of all forms of JIA-associated uveitis and compared with children without uveitis [
3,
12,
13]. The most consistently reported predictor of uveitis is young age at onset of arthritis. In line with Saurenmann et al. our data confirms that young age at arthritis onset implies high risk of uveitis in girls, but not in boys [
38]. The predictors of uveitis are different in girls and boys, even though the rate of uveitis did not differ. This may reflect that different categories of JIA have different types of uveitis with different predicting factors. ANA is another well-documented predictor of uveitis, but this applies only to the immunofluorescence method, and not to the more automatized high-throughput method of ANA ELISA. We were not able to find the gender-specific differences of ANA that Saurenmann et al. found in their Canadian study [
38], but there were few ANA positive boys with uveitis in our study.
We found increased risk of uveitis in children with high levels of antihistone antibodies. Previous findings in the Norwegian JIA cohort were now confirmed in 134 Swedish and Danish children, in whom significantly higher baseline serum levels of histone antibodies were found among those who developed uveitis compared to those who did not develop uveitis [
11]. In these studies, the histone antibody levels were either borderline positive (≥ 15 U/ml) or positive (≥ 30 U/ml) according to the commercial test, however, the test and the cut-offs are established to detect drug-induced or other types of systemic lupus erythematosus in adults [
23]. While the mean serum concentration of combined antihistone IgM and IgG antibodies was 19.2 U/ml in children with uveitis, and 10.2 U/ml in children without uveitis, a mean concentration of 4.3 U/ml was found in healthy children in our previous report utilizing the identical type of AHA EIA kit [
11]. The reproducibility of this finding should be tested in other cohorts. Epigenetic modifications of histone such as acetylation and methylation are suggested to be involved in the pathological processes of autoimmunity [
18], and may also play a role in the etiology of uveitis [
39]. However, no specific intra-ocular antigen has been identified as the target of neither ANA nor AHA, and therefore their potential role in pathophysiology and etiology remains unclear. The presence of ANA immunofluorescence and AHA had similar test properties as predictors of uveitis, but with less predictive ability as the simple measure of young age at onset of arthritis. There is an ongoing discussion on classification in JIA. ANA positive young children are a quite homogeneous group regarding disease characteristics including high risk of uveitis the first 2 years after onset [
40,
41]. It is interesting that the higher risk of uveitis in girls with young age at onset, was shown also for girls with higher levels of histone antibodies in our study. Whether young girls with uveitis, presence of ANA and AHA constitutes a biological subset among children with JIA remains to be shown.
We analyzed the onset of uveitis in relation to early DMARD treatment, and found that early DMARD or methotrexate treatment did not seem to prevent later development of uveitis. The inclusion period in our cohort was too short for analyses of prevalence in different time periods, the onset of disease was in the very beginning of the era of biologic agents, and our data are therefore of limited value in clarifying any uveitis-protective potential of specific drugs or modern DMARD treatment in general. Tappeiner et al. have compared prevalence of uveitis in German children with JIA in two time periods up to 2013, and found a lower prevalence in the latest period when DMARDs including biologic agents were more commonly used [
42]. Whether DMARDs can prevent or only postpone development of uveitis in JIA is not known.
Acknowledgements
First, we thank the children and parents participating in the study. We also thank the other members of the Nordic Study group of Pediatric Rheumatology (NoSPeR); Gudmund Marhaug in Trondheim, Freddy Karup Pedersen in Copenhagen, Pekka Lahdenne in Helsinki, Boel Anderson-Gäre in Jonköping for inspiring cooperation. Finally, we thank participating physicians contributing by collecting data; Nils Thomas Songstad, Astri Lang and Anne Elisabeth Ross in Tromsø, Kjell Berntzen and Nina Moe in Trondheim, Mikael Damgaard, Maria Ekelund and Nils Olof Jonsson, Jönköping, Anders Berner and Hans Ekström, Karlstad, Eric Ronge, Skövde, Agne Lind and Lars Hammarén, Borås, Johan Robinsson, Trollhättan and Anna-Lena Nilsson, Östersund.